The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed the day trading at $5.02 down -0.59%% from the previous closing price of $5.05. In other words, the price has decreased by -$0.59% from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
For a better understanding of AMLX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.05 and its Current Ratio is at 12.05. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on June 17, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
Mizuho Upgraded its Neutral to Outperform on April 07, 2025, while the target price for the stock was maintained at $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 31 ’25 when FRATES JAMES M sold 10,896 shares for $3.47 per share. The transaction valued at 37,806 led to the insider holds 290,988 shares of the business.
Bedrosian Camille L sold 12,425 shares of AMLX for $43,082 on Mar 31 ’25. The Chief Medical Officer now owns 194,375 shares after completing the transaction at $3.47 per share. On Mar 31 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 9,192 shares for $3.48 each. As a result, the insider received 31,954 and left with 187,969 shares of the company.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $7.27, while it has fallen to a 52-week low of $1.62. The 50-Day Moving Average of the stock is 2.31%, while the 200-Day Moving Average is calculated to be 19.98%.
Shares Statistics:
A total of 89.08M shares are outstanding, with a floating share count of 65.31M. Insiders hold about 26.74% of the company’s shares, while institutions hold 76.23% stake in the company.
